Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;9(2):110-6.
doi: 10.1016/j.jcf.2009.11.010. Epub 2009 Dec 31.

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis

Affiliations

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis

Christopher R Sudfeld et al. J Cyst Fibros. 2010 Mar.

Abstract

Background: Filamentous fungi are frequently recovered from respiratory cultures of individuals with CF.

Methods: A CF cohort database was utilized to determine filamentous fungal prevalence and risk factors.

Results: The prevalence of filamentous fungal isolation increased from 2.0% in 1997 to 28.7% in 2007. The odds of isolating filamentous fungi during a quarter was greater in CF adults [p<0.001], during chronic oral antibiotic use [p=0.002] and increased with each 10% drop in FEV(1) percent predicted [p=0.005], while inhaled corticosteroids surprisingly decreased the likelihood [p=0.012]. The direction of these effects persisted after excluding individuals with ABPA. A sub-analysis determined older age [p=0.019] and use of inhaled antibiotics [p=0.011] were independent risk factors for onset of fungal colonization.

Conclusions: This study suggests that isolation of filamentous fungi in CF at JHH has increased and risk factors include older age, decreased lung function, and chronic oral antibiotics.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None Reported

Figures

Figure I
Figure I
Percentage of Individuals Recovering at Least One Filamentous Fungal Species from Lung Culture During Each Year 1997–2007.

References

    1. Fries MH, Bashford M, Nunes M. Implementing prenatal screening for cystic fibrosis in routine obstetric practice. Am J Obstet Gynecol. 2005;192:527–34. - PubMed
    1. Brennan AL, Geddes DM. Cystic fibrosis. Curr Opin Infect Dis. 2002;15(2):175–82. - PubMed
    1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):918–51. - PubMed
    1. Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001;183(3):444–52. - PubMed
    1. Cystic Fibrosis Foundation Patient Registy. 2001 Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation; 2002.

MeSH terms

Substances